Stratos Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.22M | Sell |
8,044
-183
| -2% | -$96.1K | 0.22% | 114 |
|
|
2025
Q1 | $5.22M | Sell |
8,227
-354
| -4% | -$225K | 0.29% | 88 |
|
|
2024
Q4 | $6.11M | Sell |
8,581
-67
| -0.8% | -$47.7K | 0.29% | 82 |
|
|
2024
Q3 | $9.09M | Sell |
8,648
-30
| -0.3% | -$31.5K | 0.42% | 59 |
|
|
2024
Q2 | $9.12M | Buy |
8,678
+213
| +3% | +$224K | 0.45% | 53 |
|
|
2024
Q1 | $8.15M | Buy |
8,465
+156
| +2% | +$150K | 0.48% | 50 |
|
|
2023
Q4 | $7.3M | Hold |
8,309
| – | – | 0.42% | 51 |
|
|
2023
Q3 | $6.84M | Buy |
8,309
+266
| +3% | +$219K | 0.45% | 45 |
|
|
2023
Q2 | $5.78M | Buy |
8,043
+180
| +2% | +$129K | 0.41% | 59 |
|
|
2023
Q1 | $6.46M | Buy |
7,863
+800
| +11% | +$657K | 0.5% | 39 |
|
|
2022
Q4 | $5.1M | Buy |
7,063
+4,781
| +210% | +$3.45M | 0.42% | 57 |
|
|
2022
Q3 | $1.57M | Buy |
2,282
+322
| +16% | +$222K | 0.17% | 182 |
|
|
2022
Q2 | $1.16M | Buy |
1,960
+725
| +59% | +$429K | 0.11% | 245 |
|
|
2022
Q1 | $863K | Sell |
1,235
-759
| -38% | -$530K | 0.07% | 294 |
|
|
2021
Q4 | $1.26M | Buy |
1,994
+325
| +19% | +$205K | 0.09% | 251 |
|
|
2021
Q3 | $1.01M | Buy |
+1,669
| New | +$1.01M | 0.09% | 253 |
|
|
2021
Q2 | – | Sell |
-576
| Closed | -$273K | – | 550 |
|
|
2021
Q1 | $273K | Buy |
+576
| New | +$273K | 0.03% | 415 |
|